Developments in Carbohydrate-Based Cancer Therapeutics

Cancer cells of diverse origins express extracellular tumor-specific carbohydrate antigens (TACAs) because of aberrant glycosylation. Overexpressed TACAs on the surface of tumor cells are considered biomarkers for cancer detection and have always been prioritized for the development of novel carbohy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Farzana, Andreana, Peter R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631729/
https://www.ncbi.nlm.nih.gov/pubmed/31167407
http://dx.doi.org/10.3390/ph12020084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631729/
https://www.ncbi.nlm.nih.gov/pubmed/31167407
http://dx.doi.org/10.3390/ph12020084

Ejemplares similares